Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
1.980
-0.020 (-1.00%)
At close: May 9, 2025, 4:00 PM
2.010
+0.030 (1.52%)
After-hours: May 9, 2025, 7:58 PM EDT
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $757.38 million as of May 9, 2025. Its market cap has decreased by -19.90% in one year.
Market Cap
757.38M
Enterprise Value
-54.76M
1-Year Change
-19.90%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $757.38M, a decrease of -33.45%. That is a compound annual growth rate of -5.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 763.10M | -1.18% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 355.95B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |